Status:
COMPLETED
Major Depressive Disorder In The Elderly
Lead Sponsor:
GlaxoSmithKline
Conditions:
Depressive Disorder, Major
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
This is a placebo-controlled study evaluating the effectiveness of medication in elderly subjects with Major Depressive Disorder (MDD).
Eligibility Criteria
Inclusion
- Primary diagnosis of Major Depressive Disorder with DSM-IV criteria for their current episode for at least 8 weeks.
Exclusion
- Patient has current or past history of seizure disorder or brain injury.
- Patient has a diagnosis of anorexia or bulimia within the past 12 months.
- Patient has a past or current DMS-IV diagnosis of schizophrenia or any other psychotic disorder(s).
- Patient has had a myocardial infarction within 1 year or a history of uncontrolled hypertension or unstable heart disease with 6 months.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
364 Patients enrolled
Trial Details
Trial ID
NCT00093288
Start Date
June 1 2004
End Date
October 1 2005
Last Update
September 2 2013
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Caboolture, Queensland, Australia, 4510
2
GSK Investigational Site
Everton Park, Queensland, Australia, 4053
3
GSK Investigational Site
New Farm, Queensland, Australia, 4005
4
GSK Investigational Site
St Albans, Victoria, Australia, 3021